Member Info for Inphobe

I don't think many investors ('the market') here (certainly sellers at this price) have paid much attention to AIHL, many don't seem to even know what it is. At the end of the day there are many things in the market competing for people's attention. It will get attention when the penny drops for the majority, as these things always do.

Or to put it another way, it's definitely AIHL (imo), with I think great potential of Covid and perhaps military. That's a lot to like at this low sp with funding to next year (unlike another stock which I never liked, you know which, sorry to those over there and good luck).

Appears not to be 'over' according to the WHO

https://www.reuters.com/business/healthcare-pharmaceuticals/who-chief-scientist-pandemic-has-not-ended-more-variants-expected-2022-02-11/

Who'dve thunk it? Anyone watching actually. Point of Care that actually detects variants, yes GDR, has a long future.

Never mind that some of the negative posters here are sidelining AIHL which will put a higher floor into this fairly soon without any shadow of doubt imo. I appreciate some don't appear to know what it is lol. Gdr is now probably in the best position product wise it's ever been in, yet is being branded by some as a 'covid stock'.

I don't mind genuine pessimists Gloria but I don't particularly think just being here to knock the sp gives anyone much of a platform to knock anyone else. Anyhow, on AIHL I'm just a realist. It's going to be adopted into NHS. Watch and tell me later if I'm wrong (I'm not). Opinion only of course.

Has it occurred to you that many of us are invested for other products as well? One of which will be adopted into NHS shortly ('jmo'). Not to mention that the market for point of care Covid remains (which is what this is?). Of course it has Gloria, but you admitted directly you were only here to deramp.

Could be Lloyd, or could be flat or up. If I'm right (and some of the most 'conservative' posters agree) about AIHL being adopted into NHS (and I'll go as far as saying I have no doubt), what it does today doesn't matter in the longer scheme except as an opportunity for new investors. All JMO of course, not saying anything about the Covid product or military though I'm positive about those (could be wrong about the latter, but not about AIHL I think)

IMO given AIHL and what we know about it Franky that's not what it'll be, not saying it'll be the latter but I'm surprised some haven't twigged yet

@MrIndia no one can give you advice, but if you've done your own research you'll know why you're invested? One of my reasons is the multiple products, one of which at very least (AIHL) should in my view see recovery here (I do also think we'll see Covid sales (and military possibly) but that's another matter and as I said earlier less easy to assess). There are known things on AIHL i.e. the NICE guidance review which seems to be listed on their site for 1 March I believe, and the PALOH study release also in March, together with some other snippets picked up which lead me to be confident we will see NHS adoption of that starting shortly (JMO, as I say no-one can advise you)

It is cando and I'd also love an update on Covid though (just my view) anyone who's in now at these prices will be very tidy on AIHL news (I know we could be accused of optimism on AIHL but I don't think we are at all, reasons)

Yes starres, and going by what I've seen care homes also are far from satisfied with their current testing regimes. The cost in lives and money from covid to that sector remains huge

Don't know Lloyd (I think we had that info for previous iterations so might be worth another dig?)

Fair point Roger, I've done similar too

Last saw with US DoD was the budget proposal that came out last summer which had the products listed for various branches (I've asked before if anyone has link still?) - I don't know when we might hear if that budget comes through (if it does), but the military assay was definitely proposed for purchase in it (I might do some digging again when I get a moment but it's hard to find info)

Because it is not that expensive and has the potential to save time and money and lives in a care home / clinical situation. Not making a prediction, just answering your question hash. (not lots of competition in PoC space)

Morning system. Yes of course there is. March has aihl news due. AIHL will be adopted into NHS (imo). I happen to think we'll also see Covid sales but that's never been as easy to analyse.

Yes Jimi, saw the original of that ref AIHL you saw the other day.

It isn't. And they have AIHL which if you've researched you'll know will have news in March.

As starres says

(in response to "due to government contracts no doubt")

Doubt it. They're a US company and likely much of their sales are to into US private healthcare. Also, you know we're not talking lft's here?! Gdr's would likely also be into healthcare and industry.

https://www.abbott.com/IDNOW.html?CID=OUS_OK

https://www.globalpointofcare.abbott/en/product-details/id-now-covid-19.html

It seems so waynesmith, however it should be said that I think you're talking about lft's? Gdr's PoC lamp isn't for that market (or aimed at or expecting government purchases necessarily - none of the markets except potentially parts of healthcare I'm thinking of are government)